The Pathology and Imaging of Coronavirus Pneumonia

1st Edition - November 21, 2024
Editors: Hongjun Li, Chunming Zhang, Yingmin Ma, Sergey Ternovoy
Language: English
Paperback ISBN:
9 7 8 - 0 - 4 4 3 - 3 2 9 3 0 - 2
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 3 2 9 3 1 - 9

The Pathology and Imaging of Coronavirus Pneumonia is a comprehensive study of the coronavirus family-related pulmonary diseases, specifically targeting the three subtypes of cor… Read more

Purchase options

SPRING SALE

Bloom into spring savings!

Save up to 25% on books, eBooks and Journals!

Shop now

Institutional subscription on ScienceDirect

Request a sales quote

The Pathology and Imaging of Coronavirus Pneumonia is a comprehensive study of the coronavirus family-related pulmonary diseases, specifically targeting the three subtypes of coronaviruses that have been confirmed to infect humans: SARS, MERS, and COVID-19. It is based on heterogeneous data from imaging and clinical sources, and particularly emphasizes the imaging-based staging diagnostic model rooted in the pathogenic and pathological aspects of clinical staging, thereby aiming to better align with the requirements of evidence-based medicine in clinical diagnosis and treatment.

The book provides a comprehensive overview of the pathology and imaging manifestations of coronavirus pneumonia, covering the integrated theories and practical achievements of etiology, epidemiology, pathology, clinical diagnosis, treatment, radiology, cleaning, disinfection, and protection measures commonly used in the imaging department, as well as the prevention and prognosis of SARS, MERS and COVID-19.

Title of Book
Cover image
Title page
Table of Contents
Copyright
Contributors
About the editors
Preface
Brief introduction
List of editorial board members
Chapter 1. Overview
1.1 The discovery and types of coronaviruses
1.2 Types of human coronavirus
1.3 The hazards of coronaviruses
Chapter 2. Etiology
2.1 Morphological structure and physicochemical properties of coronaviruses
2.1.1 Morphological structure
2.1.2 Physicochemical properties
2.2 Isolation and culture of coronavirus
2.2.1 Collection of specimens
2.2.1.1 Collection objects
2.2.1.2 Requirements for specimen collection
2.2.1.3 Type of specimen collection
2.2.1.4 Method of specimen collection
2.2.1.5 Specimen packaging
2.2.1.6 Specimen storage
2.2.1.7 Specimen submission
2.2.2 Virus isolation and culture
2.3 Genetic structure and replication of coronavirus
2.3.1 Gene structure
2.3.2 Virus replication process
2.3.2.1 Adsorption and penetration
2.3.2.2 Uncoating and replication
2.3.2.3 Assembly and release
Chapter 3. Epidemiology
3.1 Epidemic profile
3.1.1 Prevalence of severe acute respiratory syndrome (SARS)
3.1.2 Prevalence of middle east respiratory syndrome (MERS)
3.1.3 Prevalence of coronavirus disease 2019 (COVID-19)
3.2 Source of infection
3.2.1 Infection source of SARS
3.2.2 Infection source of MERS
3.2.3 Infection source of COVID-19
3.3 Route of transmission
3.3.1 Transmission route of SARS
3.3.2 Transmission route of MERS
3.3.3 Transmission route of COVID-19
3.4 Susceptible population
3.4.1 Susceptible population of SARS
3.4.2 Susceptible population of MERS
3.4.3 Susceptible population of COVID-19
3.5 Epidemiologic characteristics
3.5.1 Epidemiologic characteristics of SARS
3.5.2 Epidemiologic characteristics of MERS
3.5.3 Epidemiologic characteristics of COVID-19
Chapter 4. Pathogenesis and pathophysiology
4.1 Section 1 Pathogenesis
4.1.1 Receptor binding theory
4.1.2 Immune damage theory
4.1.3 Cytokine storm theory
4.1.4 Direct damage theory
4.1.5 Endothelial injury theory
4.2 Section 2 Pathophysiology
4.2.1 Fever
4.2.2 Hypoxia
4.2.3 ARDS
4.2.4 Shock
4.2.5 Acid-base disturbance
Chapter 5. Pathological manifestations
5.1 Pathological manifestations of SARS
5.1.1 Pulmonary lesions
5.1.2 Damage to immune organs
5.1.3 Vasculopathy
5.1.4 Systemic toxic changes
5.2 Pathological manifestations of MERS
5.3 Pathological manifestations of COVID-19
5.3.1 Pulmonary lesions
5.3.1.1 Lesions in exudative stage
5.3.1.2 Lesions of proliferative stage
5.3.2 Extrapulmonary lesions
5.3.3 Underlying lesions
5.3.4 Cause of death
5.3.5 Pathological diagnosis and differential diagnosis
Chapter 6. Clinical manifestations
6.1 Clinical manifestations of SARS
6.2 Clinical manifestations of MERS
6.3 Clinical manifestations of COVID-19
6.3.1 Main manifestations and course of disease
6.3.2 Clinical classification and clinical characteristics
6.3.3 Clinical manifestations of COVID-19 in children
6.3.4 Complications
Chapter 7. Laboratory test and other tests
7.1 Blood routine test
7.2 Blood biochemistry test
7.3 Etiological examination
7.4 Serum immunological examination
7.5 Molecular biological examination
7.5.1 Real-time fluorescence RT-PCR detection of novel coronavirus nucleic acid
7.5.2 Virus gene sequencing
7.6 Blood gas analysis
7.7 Pulmonary function examination
Chapter 8. Imaging examination technologies
8.1 Coronavirus pneumonia imaging scanning scheme as well as CT and DR quality control in operating procedures
8.1.1 Fever clinic or independent DR examination scheme
8.1.1.1 Examination precautions
8.1.1.2 Imaging examination scheme
8.1.2 Bedside photographic examination scheme
8.1.2.1 Examination precautions
8.1.2.2 Imaging examination scheme
8.1.3 CT examination scheme
8.1.3.1 Examination precautions
8.1.3.2 Common examination scheme
8.1.4 Imaging examination scheme for special population
8.1.4.1 Imaging examination for children
8.1.4.2 Chest CT examination for pregnant women
8.1.5 Quality control in CT and DR operating procedures
8.1.5.1 Strictly follow correct operating procedures
8.1.5.2 Environment management
8.1.5.3 Equipment maintenance management
8.1.6 Other imaging examinations
8.2 Infection control and management measures for imaging equipment of primary hospitals and mobile cabin hospitals
8.2.1 Primary task of imaging department in primary hospital
8.2.2 Mobile cabin hospitals
8.2.3 Management requirements for imaging diagnosis inspection equipment
Chapter 9. Imaging manifestations of SARS
9.1 Imaging manifestations in early stage
9.1.1 Imaging manifestations
9.1.1.1 X-ray
9.1.1.2 CT
9.1.2 Case description
9.1.3 Diagnostic key points
9.2 Imaging manifestations in progressive stage
9.2.1 Imaging manifestations at progressive stage
9.2.1.1 X-ray
9.2.1.2 CT
9.2.2 Case description
9.2.3 Diagnostic key points
9.3 Imaging manifestations in convalescence stage
9.3.1 Imaging manifestations
9.3.1.1 Dynamic evolution of SARS imaging
9.3.1.2 Pathological basis of imaging manifestations
9.3.1.3 Imaging manifestations of complications
9.3.2 Case description
9.3.3 Diagnostic key points
Chapter 10. Imaging manifestations of MERS
10.1 Overview of MERS
10.2 Imaging manifestations and diagnosis of MERS
10.2.1 Imaging manifestations of MERS
10.2.2 Key points for imaging differential of SARS, MERS and COVID-19
10.2.3 Case description
10.2.4 Diagnostic key points
Chapter 11. Imaging manifestations of COVID-19
11.1 Imaging manifestations in early stage
11.1.1 Clinical characteristics
11.1.2 Imaging manifestations
11.1.3 Case description
11.1.4 Diagnostic key points
11.2 Imaging manifestations in progressive stage
11.2.1 Clinical characteristics
11.2.2 Imaging manifestations
11.2.3 Case description
11.2.4 Diagnostic key points
11.3 Imaging manifestations in recovery stage
11.3.1 Clinical characteristics
11.3.2 Imaging manifestations in recovery stage
11.3.3 Case description
11.3.4 Diagnostic key points
11.4 Imaging manifestations of severe and critical patients
11.4.1 Clinical characteristics
11.4.2 Imaging manifestations
11.4.3 Case description
11.4.4 Diagnostic key points
11.5 Imaging manifestations of special population
11.5.1 Infants and young children
11.5.1.1 Clinical characteristics
11.5.1.2 Imaging manifestations
11.5.1.3 Case description
11.5.1.4 Diagnostic key points
11.5.2 Children and adolescents
11.5.2.1 Clinical characteristics
11.5.2.2 Imaging manifestations
11.5.2.3 Case description
11.5.2.4 Diagnostic key points
11.5.3 Patients in midtrimester pregnancy
11.5.3.1 Case description
11.5.3.2 Diagnostic key points
11.5.4 The elderly
11.5.4.1 Clinical characteristics
11.5.4.2 Imaging manifestations
11.5.4.3 Case description
11.5.4.4 Diagnostic key points
11.5.5 Patients with underlying diseases
11.5.5.1 Clinical characteristics
11.5.5.2 Imaging manifestations
11.5.5.3 Case description
11.5.5.4 Diagnostic key points
11.6 Imaging manifestation of re-positive cases of viral nucleic acid testing
11.6.1 Clinical characteristics
11.6.2 Imaging manifestations
11.6.3 Case description
11.6.4 Diagnostic key points
11.7 Imaging manifestations of asymptomatic infected persons
11.7.1 Clinical characteristics
11.7.2 Imaging manifestations of asymptomatic infected persons
11.7.3 Case description
11.7.4 Diagnostic key points
11.8 Imaging manifestations of COVID-19 complications
11.8.1 Clinical characteristics
11.8.2 Imaging manifestations of COVID-19 complications
11.8.2.1 Respiratory complications
11.8.2.2 Circulatory complications
11.8.2.3 Digestive complications
11.8.2.4 Neurological complications
11.8.3 Case description
11.8.4 Diagnostic key points
11.9 Imaging manifestations of heart disease with COVID-19
11.9.1 Clinical characteristics
11.9.2 MR manifestations of heart diseases
11.9.3 Case description
11.9.4 Diagnostic key points
11.10 Imaging manifestations of neurological lesions with COVID-19
11.10.1 Clinical characteristics
11.10.2 Imaging manifestations of neurological lesions
11.10.3 Case description
11.10.4 Diagnostic key points
11.11 Imaging manifestations of digestive system lesions with COVID-19
11.11.1 Clinical characteristics
11.11.2 Imaging manifestations of digestive system lesions
11.11.3 Case description
11.11.4 Diagnostic key points
Chapter 12. Application of AI in COVID-19
12.1 Application of AI in radiology
12.1.1 Application of the “Tianyan AI Platform”
12.1.2 AI-assisted COVID-19 diagnosis
12.1.3 Remote AI diagnosis platform for COVID-19 based on expert system
12.2 AI-assisted COVID-19 diagnosis
12.2.1 Earning screening of suspected COVID-19 patients
12.2.2 Quantitative analysis of COVID-19 pulmonary lesions
12.2.3 Differential diagnosis with non-COVID-19
Chapter 13. Imaging differential diagnosis
13.1 Imaging differential diagnosis of SARS
13.1.1 Differentiation of SARS from other pneumonia
13.1.1.1 Differentiation of SARS from pneumonia in patients with normal immune functions
13.1.1.2 Differentiation of SARS from pneumonia in patients with impaired immune functions
13.1.2 Differentiation of SARS from noninflammatory diseases
13.1.3 Differentiation of SARS from ARDS
13.2 Imaging differential diagnosis of MERS
13.2.1 Imaging differentiation of MERS from SARS
13.2.2 Imaging differentiation of MERS from human-infected H7N9 avian influenza
13.2.3 Differentiation of MERS from pneumocystis jiroveci pneumonia
13.3 Imaging differential diagnosis of COVID-19
13.3.1 Differentiation of COVID-19 from influenza A (H3N2) virus
13.3.2 Differentiation of COVID-9 from mycoplasma pneumoniae pneumonia
13.3.3 Differentiation of COVID-19 from mycotic pneumonia
13.3.4 Differentiation of COVID-19 from lupus pneumonitis
13.3.5 Differentiation of COVID-19 from cardiogenic pulmonary edema combined with pulmonary infection
Chapter 14. Diagnosis and treatment
14.1 Diagnostic criteria
14.1.1 Diagnostic criteria of COVID-19
14.1.1.1 Suspected cases
14.1.1.2 Confirmed cases
14.1.2 Diagnostic criteria of SARS
14.1.2.1 Medical isolation observer
14.1.2.2 Suspected cases
14.1.2.3 Clinical diagnosis and definitive diagnosis
14.1.2.4 Diagnostic criteria of severe SARS
14.1.3 Diagnostic criteria of MERS
14.1.3.1 Suspected cases
14.1.3.2 Clinically diagnosed cases
14.1.3.3 Confirmed cases
14.2 Treatment principle
14.2.1 Determine the treatment place according to the disease conditions
14.2.2 Principle of SARS treatment
14.2.3 Principle of MERS treatment
14.3 General treatment and supporting treatment
14.3.1 General treatment
14.3.2 Supportive treatment
14.3.2.1 Respiratory support
14.3.2.2 Circulatory support
14.3.2.3 Anticoagulation treatment
14.3.2.4 Acute kidney injury and renal replacement therapy
14.3.2.5 Blood purification treatment
14.3.2.6 Multisystem inflammatory syndrome in children
14.3.2.7 Other treatment measures
14.3.3 Treatment of SARS
14.3.3.1 General treatment and disease monitoring
14.3.3.2 Symptomatic treatment
14.3.3.3 Use of glucocorticoids
14.3.3.4 Antiviral treatment
14.3.3.5 Immunotherapy
14.3.3.6 Use of antimicrobial agents
14.3.3.7 Psychotherapy
14.3.3.8 Treatment principles of severe SARS
14.3.4 Treatment of MERS
14.3.4.1 General treatment and close monitoring
14.3.4.2 Antiviral treatment
14.3.4.3 Antibiotics treatment
14.3.4.4 TCM treatment
14.3.4.5 Treatment suggestions for severe cases
14.4 Antiviral treatment
14.4.1 Antiviral treatment of SARS
14.4.2 Treatment of MERS
14.5 Use of glucocorticoids and immunomodulators
14.5.1 Application of glucocorticoids and immunomodulator in SARS treatment
14.5.2 Application of glucocorticoids and immunomodulator in MERS treatment
14.6 Application of mechanical ventilation and ECMO
14.6.1 Nasal cannula and mask oxygen therapy
14.6.2 HFNC or NIV
14.7 TCM diagnosis and treatment
14.7.1 TCM diagnosis and treatment of SARS
14.7.1.1 Etiology and pathogenesis
14.7.1.2 Syndrome differentiation and treatment
14.7.2 TCM diagnosis and treatment of MERS
14.7.3 TCM diagnosis and treatment of COVID-19
14.7.3.1 Medical observation period
14.7.3.2 Clinical treatment period (confirmed cases)
Chapter 15. Prevention and prognosis
15.1 Prevention and control measures
15.2 Management source of infection
15.3 Cut-off of transmission routes
15.4 Protection of susceptible population
15.5 Prognosis
15.5.1 Prognosis of COVID-19
15.5.2 Prognosis and prevention of SARS and MERS
Chapter 16. Commonly used cleaning and disinfection methods and medical waste handling in Radiology Departments
16.1 Commonly used cleaning and disinfection methods
16.1.1 Disinfection of DR and CT rooms for COVID-19 in Radiology Department
16.1.1.1 Equipment disinfection
16.1.1.2 Disinfection of object surface
16.1.1.3 Air disinfection
16.1.1.4 Ground disinfection
16.1.1.5 Terminal disinfection
16.1.2 Disinfection of general DR and CT rooms in Radiology Department
16.1.2.1 Equipment disinfection
16.1.2.2 Disinfection of object surface
16.1.2.3 Air disinfection
16.1.2.4 Ground disinfection
16.1.3 Disinfection of mobile DR/CT
16.1.4 Disinfection of registry/film pickup room
16.1.4.1 Facility disinfection
16.1.4.2 Ground disinfection
16.1.4.3 Reduce contact
16.1.5 Regular cleaning and disinfection of daily living areas
16.2 Medical waste handling in Imaging Departments
16.2.1 Classification and collection of medical wastes
16.2.1.1 Clarify the range of classification and collection
16.2.1.2 Specify the packaging container
16.2.1.3 Conduct collection safely
16.2.1.4 Handle by zone
16.2.2 Transport of medical wastes
Chapter 17. Strategies for prevention and control of nosocomial infection and X-ray protection principles in radiology departments
17.1 Strategies for prevention and control of nosocomial infection
17.1.1 Diagnosis and treatment environments and post requirements of radiology department
17.1.1.1 Requirements for diagnosis and treatment environment
17.1.1.2 Post requirements
17.1.2 Working mode of radiographers in key areas (trial)
17.1.3 Prevention principle for nosocomial infection in radiology department
17.1.4 Patient protection and management
17.1.5 Personnel training
17.2 X-ray protection against nosocomial infection in radiology department
17.2.1 Basic principles of radiation protection
17.2.2 Application of mobile DR/CT
17.2.2.1 Site clearing before exposure
17.2.2.2 Use of protective equipment
Chapter 18. Coronavirus Infection control during the process of imaging examination
18.1 Setup and construction of CT room in fever clinic
18.1.1 Set up CT examination room in fever clinic area
18.1.2 Set up a dedicated CT examination channel from the fever clinic
18.1.3 Set up a dedicated waiting areas for patients from the fever clinic outside the CT room
18.1.4 Provide quick-drying hand sanitizer inside and outside the door of different areas
18.1.5 Strengthen the management of dedicated CT exhaust vents
18.2 Infection control and management in imaging department of fever clinic
18.2.1 Establish a sound management system for CT room in the fever clinic
18.2.2 Strengthen the training, assessment and supervision of infection control for imaging staff
18.2.3 Scientifically and reasonably set up the on-duty post of imaging department
18.3 CT examination process of fever clinic
18.3.1 Preparation before CT examination
18.3.2 Clinical reception of patients
18.3.3 Examination of patients
18.3.4 Image and report processing
18.3.5 Other precautions
Appendix 1. Guidelines for imaging diagnosis of novel coronavirus pneumonia in both Chinese and English versions (third edition 2021)
1 Clinical diagnosis of COVID-19
1.1 Scope of application
1.2 Diagnosis basis
1.2.1 Clinical manifestations
1.2.2 Imaging manifestations
1.2.3 Laboratory tests
1.2.4 Diagnostic criteria
2 Recommended methods for imaging examinations
2.1 Chest X-ray examination
2.2 Chest CT examination
3 Imaging manifestations
3.1 Infants and young children
3.1.1 Clinical features
3.2 Children and adolescents
3.2.1 Clinical features
3.2.2 Imaging manifestations chest X-ray manifestations
3.2.3 Chest CT manifestations
3.3 Pregnant women
3.3.1 Clinical features
3.3.2 Chest CT manifestations
3.4 The elderly
3.4.1 Clinical features
3.4.2 Imaging manifestations chest X-ray manifestations
3.4.3 Chest CT manifestations
3.5 Patients with underlying diseases
3.5.1 Clinical features
3.5.2 Imaging manifestations
3.6 Asymptomatic infected persons
3.6.1 Definition of asymptomatic infected persons
3.6.2 Clinical characteristics of asymptomatic infected persons
3.6.3 Imaging manifestations
3.7 Re-positive cases of SARS-CoV-2 nucleic acid test
3.7.1 Clinical manifestations
3.7.2 Imaging manifestations
3.8 Imaging differential diagnosis
3.8.1 Distinguishing from other viral pneumonias
3.8.2 Distinguishing from nonviral infectious pneumonia
3.8.3 Differentiation from noninfectious lung lesions
3.8.4 Value of imaging examinations in diagnosis and treatment of COVID-19
3.9 AI-assisted COVID-19 diagnosis
4 Implementation, promotion and updating of COVID-19 imaging diagnostic guidelines
4.1 Implementation and promotion of the COVID-19 imaging diagnostic guidelines involve the estimation of favorable and unfavorable factors
4.1.1 Favorable factors
4.1.2 Adverse factors
5 Appendix A: Supplement of diagnostic guidelines for COVID-19 in children, infants and young children
6 Appendix B: Imaging examination protection and technical parameters
7 Appendix C: Guidelines for prevention and control of nosocomial infections during radiological examination of COVID-19
8 Appendix D: Procedures for medical staff to don and doff protective equipment
9 Appendix E: Radiological protection in imaging examination of novel coronavirus–infected pneumonia
Appendix 2. Expert consensus on radiological examination scheme and infection prevention and control of COVID-19 (trial first edition)
1 Characteristics, clinical manifestations, and reporting procedures of COVID-19 [7]
1.1 Etiology characteristics
1.2 Epidemiologic characteristics
1.2.1 Source of infection
1.2.2 Route of transmission
1.2.3 Susceptible population
1.3 Clinical manifestations
1.4 Clinical classification
2 Strategies for prevention and control of nosocomial infection in radiology department
2.1 Diagnosis and treatment environments and post requirements of radiology department
2.2 Rules for prevention and control of nosocomial infection in radiology department
2.2.1 Requirements for department staff
2.2.2 Personal protection level
2.2.3 Procedures for radiology staff to don and doff protective equipment [13]
2.3 Equipment cleaning and disinfection of radiology department
2.3.1 Daily cleaning
2.3.2 Equipment disinfection
2.3.3 Floor disinfection
2.4 Handling measures of medical wastes in radiology department
2.4.1 Management regulations
2.4.2 Medical waste collection process
2.4.3 Personnel protection
3 Radiological examination scheme for novel coronavirus pneumonia
3.1 DR examination scheme
3.1.1 Examination precautions
3.1.2 Radiological examination scheme
3.2 Examination scheme of mobile bedside X-ray photograph
3.2.1 Examination precautions
3.2.2 Radiological examination scheme
3.3 CT examination scheme
3.3.1 Examination precautions
3.3.2 Commonly-used examination scheme
3.4 Other radiological examinations
Explanation of ethical and conflict of interest statements
Index

Hongjun Li

Dr. Hongjun Li is Professor and Chief Physician at the Beijing YouAn Hospital, Capital Medical University, China. He is Chairman of several key governmental committees (for example: Chairman of the Professional Committee of Radiology in National Health Technology Promotion Inheritance and Application Project of National Health Commission, the Chairman of the Specialized Committee for Radiology of Infection and Inflammation of the Chinese Research Hospital Association). He has published more than 200 papers in Chinese and English and won 10 provincial and ministerial awards, including the China Medical Science and Technology Award; he has also been granted 30 patents and edited many monographs.

Affiliations and expertise

Professor and Chief Physician, Beijing YouAn Hospital, Capital Medical University, China

Chunming Zhang

is surgical chief physician, secondary professor, master tutor, Henan University, the affiliated infectious disease hospital of Henan province (sixth people’s hospital of Zhengzhou city), vice secretary of party committee of China medical doctor association of obesity and diabetes surgery committee, director of clinical medical research center, vice President of Henan province, director of the AIDS professional committee of the committee. He has been awarded the honors of “Academic and Technical Leader of Zhengzhou,” “Top Professional and Technical Talents of Zhengzhou,” “Young and Middle-aged Health Science and Technology Innovation Talents in Henan Province,” Advanced Individual of Disease Preventionand Control in Henan Province, personal achievements of medical personnel in the new stage of epidemic prevention and control in Henan Province in 2022, and the ninth batch of “People’s Good Doctors” in China. He has published 2 monographs, published more than 30 academic papers, and won 3 scientific and technological achievements awards at or above the municipal department level.

Affiliations and expertise

Surgical chief physician, secondary professor, master tutor, Henan University, China

Yingmin Ma

Doctor of Medicine, chief physician, professor, doctoral supervisor. Deputy Secretary of the Party Committee and President of Beijing You 'an Hospital Affiliated to Capital Medical University; Director, Beijing Institute of Hepatology; Director, Beijing Institute of Infectious Diseases of Integrated Chinese and Western Medicine; Director of Beijing Institute for Prevention and Treatment of Venereal Diseases; You an liver disease infection disease specialist medical alliance chairman.

As the person in charge, he has successively undertaken major projects of the Ministry of Science and Technology, National Natural Fund, Beijing Traditional Chinese Medicine Science and Technology Project, Beijing Health System "ten hundred thousand" talent funding project, first medical development Fund project, Beijing Science and Technology Plan project (" Capital characteristics "special project) National science and technology support plan project; Beijing Medical Management Center sail plan key projects, Beijing Science and Technology Commission of the capital characteristics, capital cultivation and other topics of research work.

Awards: He has won two second prize and one third prize for military science and technology progress.Won the second prize of National Science and Technology progress

Social part-time job:He is also the chairman of the Branch of Infectious Disease Hospital of Chinese Hospital Association. Member of Critical Care Medicine Group of the Ninth Committee of Respiratory Society of Chinese Medical Association; Chairman of Anti-infective Pharmacology Committee of Beijing Pharmacological Society; Executive Director of the 4th Council of Beijing Pharmacological Society; Deputy Chairman of the Professional Committee of Drug Clinical Evaluation, Chinese Pharmaceutical Society; Standing Member of Therapeutic Drug Monitoring and Research Committee of Chinese Pharmacological Society; Executive Director of Infectious Diseases Committee, Chinese Medical Education Association; Deputy Chairman of the Ninth Committee of the Respiratory Branch of Beijing Medical Association; Standing Member, Branch of Allergy (Allergy) Reaction, Beijing Medical Association; Member of the 9th Council of China Anti-Cancer Association; Editorial member of the Chinese Journal of Respiratory and Tuberculosis.

Affiliations and expertise

Doctor of Medicine, chief physician, professor, doctoral supervisor. Deputy Secretary of the Party Committee and President of Beijing You 'an Hospital Affiliated to Capital Medical University, China.

Sergey Ternovoy

EDUCATION AND ACADEMIC QUALIFICATIONS:

1972 – Graduated from Odessa State Medical University, speciality – general practitioner

1975 – Postgraduate Course in Radiology at Odessa State Medical University

1977 – Candidate of Med. Sci. Degree Thesis (MD)

1979 – Chief of CT Department at Governmental Hospital, Moscow

1984 – PhD Thesis

1989 – Head of Radiology Department of Central Scientific Research Laboratory at Governmental Hospital

1989 – Awarded with the State Prize of USSR in Medicine.

1990 – Chief of Tomography Department at Cardiology Research Center, Moscow

1993 – Professor, Head of Radiology Chair at Academy of Postgraduate Training, Moscow

1996 – Professor, Head of Radiology Chair of Sechenov First Moscow State Medical University

1997 – Member-correspondent of Russian Academy of Medical Science (RAMS).

1999 – Full member (academician) of Russian Academy of Medical Science (RAMS)

2004 – Full member (academician) of Russian Academy of Science (RAS)

2011 – Government Award in Education

2014 – Honored Scientist Title (З №265170)

Publications:

Over 650 articles, 54 monographs, over 30 patents.

Chief of more than 35 MD and PhD thesis.

Member of editorial boards of medical journals:

Founder and Deputy Editor-in-Chief – “Russian Electronic Journal of Radiology”

Member of “Russian Journal of Radiology”

Member of “Medical vizualisation”

Member of “Clinical vizualisation”

Member of “Diagnostic and interventional Radiology”

Member of “Modern Technologies in Medicine”

Member of “Questions in Medical Practice”

Main field of interests:

Modern digital modalities in radiology: CT, MRI, US and Digital Radiology, hybrid imaging technology.

Graduate and postgraduate education.

Main awards:

· Laureate of the State Award for the series of works “New diagnostic and intensive therapy methods in blood diseases”. Diploma #19455 (3.11.1987).

· Order of Friendship for the achievements and many years of diligent work #1797 (18.12.2008).

· Medal for Merit in Radiology Field. The decision of the Presidium of Saint Petersburg Radiological Society #32 (25.02.2009).

· Europaische Akademie der Naturwissenschften. WC. RONTGEN-MEDAILLE fur besondere Verdiente um die Wissenschaftlichen Forschungen ausgezeichnet. #51, Hannover, den 10.08.2011.

· Government Award in Education 2011. Government of the Russian Federation Decree #1946-p (3.11.11).

Affiliations and expertise

Head of Radiology Chair of Sechenov First Moscow State Medical University, Russia

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

The Pathology and Imaging of Coronavirus Pneumonia

Purchase options

Bloom into spring savings!

Institutional subscription on ScienceDirect

Hongjun Li

Chunming Zhang

Yingmin Ma

Sergey Ternovoy

Related books